Claritev (CTEV) SVP granted 1,169 restricted stock units on year-end

Rhea-AI Filing Summary

Claritev Corp executive Brock Albinson reported an equity award. On December 31, 2025, the SVP and Chief Accounting Officer received 1,169 shares of Class A common stock at $0 per share, reported as a grant of restricted stock units.

The restricted stock units vest in four equal installments of 25% each on December 31, 2026, 2027, 2028 and 2029. Following this grant, Albinson directly beneficially owns 3,994 Class A common shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Albinson Brock

Role SVP, Chief Accounting Officer

Type	Security	Shares	Price	Value
Grant/Award	Class A common stock, par value $0.0001 per share	1,169	$0.00	--

Holdings After Transaction: Class A common stock, par value $0.0001 per share — 3,994 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Albinson Brock

(Last) (First) (Middle)

C/O CLARITEV CORPORATION

7900 TYSONS ONE PLACE, SUITE 400

(Street)

MCLEAN VA 22102

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Claritev Corp [ CTEV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
12/31/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A common stock, par value $0.0001 per share	12/31/2025		A(1)		1,169	A	$0	3,994	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of restricted stock units which will vest at a rate of 25% per year on each of December 31, 2026, 2027, 2028 and 2029.

Remarks:

	/s/ Kent Bartholomew, attorney-in-fact	02/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Claritev (CTEV) report for Brock Albinson?

Claritev reported an equity grant to Brock Albinson. On December 31, 2025, he received 1,169 shares of Class A common stock at $0 per share, reflecting a grant of restricted stock units that will vest over four years starting December 31, 2026.

How many Claritev (CTEV) shares does Brock Albinson own after this Form 4?

After the reported grant, Brock Albinson directly owns 3,994 shares. The Form 4 shows his beneficial ownership increasing due to 1,169 Class A common shares received as a restricted stock unit grant, with future vesting through December 31, 2029.

What are the vesting terms of Brock Albinson’s Claritev (CTEV) restricted stock units?

The restricted stock units vest in four equal annual installments. They vest 25% per year on each of December 31, 2026, 2027, 2028 and 2029, aligning the SVP and Chief Accounting Officer’s compensation with longer-term Claritev performance.

What role does Brock Albinson hold at Claritev (CTEV) in this Form 4?

Brock Albinson is Claritev’s SVP and Chief Accounting Officer. The Form 4 identifies him as an officer, not a director or 10% owner, and reports his directly held Class A common stock resulting from a restricted stock unit grant on December 31, 2025.

Was the Claritev (CTEV) equity grant to Brock Albinson a purchase or a free award?

The equity grant was reported at a price of $0 per share. The Form 4 shows transaction code “A” for acquisition and indicates 1,169 Class A common shares acquired as a restricted stock unit award rather than an open-market purchase.